<?xml version="1.0" encoding="ISO-8859-1"?>

<!DOCTYPE rss PUBLIC "-//Netscape Communications//DTD RSS 0.91//EN"
 "http://my.netscape.com/publish/formats/rss-0.91.dtd">

<rss version="0.91">

<channel>
<title>Indian Pharma Observer</title>
<link>http://www.indianpharmaobserver.com</link>
<description>Indian Pharma Observer - Admin Section</description>
<language>en-us</language>

<item>
<title>Pharma Dept plans to introduce quality mark for generic drugs</title>
<link>http://www.indianpharmaobserver.com/modules.php?name=News&amp;file=article&amp;sid=1924</link>
<description>The Department of Pharmaceuticals is planning to make another attempt to introduce quality mark on the lines of the ISI or the Agmark approvals for generic drugs manufactured and sold in the country, for ensuring quality of medicines and helping the consumers to identify it.</description>
</item>

<item>
<title>NPPA cuts down prices 3 bulk drugs, raised prices of 3 others</title>
<link>http://www.indianpharmaobserver.com/modules.php?name=News&amp;file=article&amp;sid=1923</link>
<description>The National Pharmaceutical Pricing Authority (NPPA) has cut prices of three bulk drugs, two of them by nearly 50 per cent, and increased prices of three other bulk drugs including human insulin.</description>
</item>

<item>
<title>SRL Ranbaxy is now Super Religare Labs</title>
<link>http://www.indianpharmaobserver.com/modules.php?name=News&amp;file=article&amp;sid=1922</link>
<description>SRL Ranbaxy Ltd, India&amp;rsquo;s largest pathology laboratory network, has been rechristened as Super Religare Laboratories Ltd (SRL) to make best use of cross synergies to take the business to the next level of growth.</description>
</item>

<item>
<title>KSPC set to enforce section 42 of Pharmacy Act throughout state</title>
<link>http://www.indianpharmaobserver.com/modules.php?name=News&amp;file=article&amp;sid=1921</link>
<description>&lt;div&gt;The Kerala State Pharmacy Council (KSPC) is all set to enforce the Section 42 of the Pharmacy Act, 1948 by ensuring services of a pharmacist in each pharmacy outlet in the state. With this objective, the council is planning to launch a registration renewal and survey campaign within next two months.&lt;/div&gt;</description>
</item>

<item>
<title>Arbro Pharma ties up with Prof Bhatnagar for DST-backed anthrax vaccine project</title>
<link>http://www.indianpharmaobserver.com/modules.php?name=News&amp;file=article&amp;sid=1920</link>
<description>&lt;div&gt;In order to develop an effective regime to neutralize the effects of anthrax, Delhi-based Arbro Pharmaceuticals Ltd has teamed up with renowned scientist Prof Rakesh Bhatnagar for a collaborative project under the Drugs and Pharmaceuticals Research Programme of the Department of Science and Technology.&lt;/div&gt;</description>
</item>

<item>
<title>No headway in govt-industry meeting on generic stores</title>
<link>http://www.indianpharmaobserver.com/modules.php?name=News&amp;file=article&amp;sid=1919</link>
<description>&lt;div&gt;Not much progress was made in the government-industry meeting convened by the ministry of chemicals on September 26 to get the industry support to the proposal to set up generic drug stores in each district of the country.&lt;/div&gt;</description>
</item>

<item>
<title>NPPA&amp;#039;s first information facilitation centre launched in Chennai</title>
<link>http://www.indianpharmaobserver.com/modules.php?name=News&amp;file=article&amp;sid=1918</link>
<description>The new initiative of National Pharmaceutical Pricing Authority, 'NPPA-CIFG' was launched in Chennai by the minister of state for chemicals, fertilizers and mines B K Handique.</description>
</item>

<item>
<title>Indian pharma industry poised for exciting times ahead: Zinnov study</title>
<link>http://www.indianpharmaobserver.com/modules.php?name=News&amp;file=article&amp;sid=1917</link>
<description>Driven by increasing R&amp;amp;D costs, which in turn will compel pharmaceutical organizations in the US and EU to look for new low cost R&amp;amp;D destinations such as India and China, the Indian pharmaceutical off-shoring industry is slated to become a USD 2.5 billion opportunity by 2012, according to a study conducted by Zinnov Management Consulting, one of the leading management consultancy firms in India.</description>
</item>

<item>
<title>KCI bags ICC award for Social Responsibility</title>
<link>http://www.indianpharmaobserver.com/modules.php?name=News&amp;file=article&amp;sid=1916</link>
<description>The New Delhi-based Kanoria Chemicals and Industries Limited (KCI), India's leading manufacturer of chemical intermediates, has bagged the Social Responsibility for the year 2007 award instituted by the Indian Chemical Council, the apex industry body for the Indian chemicals industry.</description>
</item>

<item>
<title>FIP&amp;#039;s bureau meet on Jan 31 in Delhi</title>
<link>http://www.indianpharmaobserver.com/modules.php?name=News&amp;file=article&amp;sid=1915</link>
<description>&lt;div&gt;The Indian pharmacy profession and education is poised to get a big global exposure as the International Pharmaceutical Federation (FIP), a 120-member global body of national associations of pharmacists and pharmaceutical scientists, is holding its next bureau meeting (executive committee meeting) in India.&lt;/div&gt;</description>
</item>

</channel>
</rss>